Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Apr 26 2024 12:00
    73,730.16 -609.28 (-0.82%)
  • NIFTY Apr 26 2024 12:00
    22,419.95 -150.40 (-0.67%)
  • SENSEX Apr 26 2024 12:00
    73,730.16 -609.28 (-0.82%)
  • NIFTY Apr 26 2024 12:00
    22,419.95 -150.40 (-0.67%)
  • Nasdaq Apr 27 2024 04:30
    15,927.90 +316.14 ( +2.03%)
  • DJIA Apr 27 2024 04:30
    38,239.66 +153.86 ( +0.40%)
  • S&P 500 Apr 27 2024 04:30
    5,099.96 +51.54 ( +1.02%)
  • Hang Seng Apr 26 2024 02:10
    17,651.15 +366.61 ( +2.12%)
  • Crude Oil Apr 26 2024 11:29
    6,995.00 -4.00 (-0.06%)
  • Gold Apr 26 2024 11:29
    71,486.00 -14.00 (-0.02%)
  • Silver Apr 26 2024 11:29
    80,745.00 +65.00 ( +0.08%)
  • Copper Apr 26 2024 11:29
    859.50 +11.10 ( +1.31%)
  • Pound / Rupee Dec 23 2016 22:30
    104.10 +0.39 ( +0.38%)
  • Dollar / Rupee Dec 23 2016 22:30
    83.32 +0.01 ( +0.01%)
  • Euro / Rupee Dec 23 2016 22:30
    89.30 +0.19 ( +0.22%)
  • Yen / Rupee Dec 23 2016 22:30
    0.54 0.00 (-0.34%)

BSE Code : | NSE Symbol : | ISIN:| SECTOR : |

NSE BSE
 

Volume

Prev. Close

Open Price

Bid Price (QTY)

Offer Price (QTY)

 

Today’s High/Low -

52 wk High/Low -

Key Stats

MARKET CAP (RS CR) 241.32
P/E 16.03
BOOK VALUE (RS) 166.8206226
DIV (%) 1000
MARKET LOT 1
EPS (TTM) 24.89
PRICE/BOOK 2.3911911715884
DIV YIELD.(%) 25.07
FACE VALUE (RS) 10
DELIVERABLES (%)
4

News & Announcements

14-Feb-2024

Narmada Gelatines standalone net profit declines 39.36% in the December 2023 quarter

09-Feb-2024

Narmada Gelatines to table results

06-Jan-2024

Narmada Gelatines Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

29-Nov-2023

Narmada Gelatines Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

09-Feb-2024

Narmada Gelatines to table results

02-Nov-2023

Narmada Gelatines to conduct board meeting

30-Aug-2023

Narmada Gelatines to convene AGM

10-Aug-2023

Narmada Gelatines to table results

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Aarti Industries Ltd 524208 AARTIIND
Aarti Surfactants Ltd 543210 AARTISURF
Aarti Surfactants Ltd Partly Paidup 890180 AARTIPP
Absolute Aromatics Ltd 40209
Aditya Info-Soft Ltd 530693
Advance Petrochemicals Ltd 506947
Aether Industries Ltd 543534 AETHER
Alang Industrial Gases Ltd 531517
Alkali Metals Ltd 533029 ALKALI
Alkyl Amines Chemicals Ltd 506767 ALKYLAMINE
Allied Resins & Chemicals Ltd(merged) 524538 ALLIEDRES
Alufluoride Ltd 524634
Amal Ltd 506597
Ambani Organics Ltd 535097 AMBANIORG
Ambica Agarbathies Aroma & Industries Ltd 532335 AMBICAAGAR
Amex Carbonates & Chemicals Ltd 531321
Amines & Plasticizers Ltd 506248 AMNPLST
Aminex Chemicals Ltd (Wound-up) 524386
Amit Alcohol & Carbon Dioxide Ltd (Merged) 506904
Anan Drug & Chem Ltd 531999
Andhra Petrochemicals Ltd 500012 ANDHRAPET
Anjana Explosives Ltd 40329
Anupam Rasayan India Ltd 543275 ANURAS
Arabian Petroleum Ltd 77164 ARABIAN
Archean Chemical Industries Ltd 543657 ACI
Archit Organosys Ltd 524640
ARCL Organics Ltd 543993
Arvee Laboratories (India) Ltd 535050 ARVEE
Arvin Liquid Gases Ltd 523404
Asiatic Oxygen Ltd 40030
Atul Ltd 500027 ATUL
Avikem Resins Ltd 523784
B L Industries (India) Ltd 530637
Balaji Amines Ltd 530999 BALAMINES
Barium Chemcials Ltd 506275
Baroda Carbons Ltd 523527
BASF India Ltd 500042 BASF
Benzo Petro International Ltd 524737
Benzo Petrochemicals Ltd (Wound Up) 524196
Bhagawati Gas Ltd 500051 BAGWATIGAS
Bhagawati Oxygen Ltd 509449
Bhatia Colour Chem Ltd 543497
Bhuruka Gases Ltd 509728
Bhuvan Tripura Industries Ltd 524725
Binaca Synthetic Resins Ltd 514344
Borax Morarji Ltd(Merged) 506315
Burmah Petro Products Ltd 40310
C J Gelatine Products Ltd 507515
Cabot India Ltd 506700 CABOTINDIA
Camlin Fine Sciences Ltd 532834 CAMLINFINE
Canvay Chemicals Ltd 531535
Caprolactam Chemicals Ltd 507486
Carbon & Chemicals India Ltd (Merged) 505813
Castrol India Ltd 500870 CASTROLIND
Cellulose Products of India Ltd 506345
Chembond Chemicals Ltd 530871 CHEMBOND
Chemcon Speciality Chemicals Ltd 543233 CHEMCON
Chemcrux Enterprises Ltd 540395
Chemfab Alkalis Ltd 541269 CHEMFAB
Chemiesynth (Vapi) Ltd 539230
Chemplast Sanmar Ltd 543336 CHEMPLASTS
Chimique Laboratories (India) Ltd 40300
Ciba India Ltd(merged) 532184 CIBASPEC
Cilson Organics Ltd 532147
Citric India Ltd 506370
Citurgia Biochemicals Ltd 506373 CITURGIBIO
Clariant (India) Ltd(merged) 500373 CLARIANT
Clarisis Organics Ltd 524806
Claro India Ltd 524366
Clean Science & Technology Ltd 543318 CLEAN
Cochin Minerals & Rutile Ltd 513353
Continental Petroleums Ltd 523232
Core Organics Ltd 524466
Crestchem Ltd 526269
Dai-ichi Karkaria Ltd 526821 DAICHIKARK
DDev Plastiks Industries Ltd 543547
Deccan Petroleums Ltd 526375
Deepak Fertilizers & Petrochemicals Corp Ltd 500645 DEEPAKFERT
Deepak Nitrite Ltd 506401 DEEPAKNTR
Diamines & Chemicals Ltd 500120 DIAMINESQ
DIC India Ltd 500089 DICIND
Diviya Chemicals Ltd 506810
DMCC Speciality Chemicals Ltd 506405 DMCC
Doctors Biotech India Ltd 512079
Dujodwala Paper Chemicals Ltd 524276
Eiko Lifesciences Ltd 540204
Eiko Lifesciences Ltd Partly Paidup 890189
Elantas Beck India Ltd 500123 DRBECK
Ellenbarrie Industrial Gases Ltd 590087
Emmessar Biotech & Nutrition Ltd 524768
EPIC Enzymes Pharma & Industrial Chemicals Ltd 524374
Fairchem Organics Ltd 543252 FAIRCHEMOR
Ficom Organics Ltd(merged) 506443 FICOMORGAN
Fine Organic Industries Ltd 541557 FINEORG
Fineotex Chemical Ltd 533333 FCL
Foseco India Ltd 500150 FOSECOIND
Futuristic Offshore Services and Chemical Ltd 500154 GANESHANHY
Gagan Gases Ltd 524624
Galaxy Oleo-Chem (India) Ltd 40207
Galaxy Surfactants Ltd 540935 GALAXYSURF
GBL Industries Ltd 539009
GHCL Ltd 500171 GHCL
Glory Chemicals Ltd 531532
GOCL Corporation Ltd 506480 GOCLCORP
Godrej Industries Ltd 500164 GODREJIND
Goiex Michio Sudo Ltd 507978
GOM Industries Ltd 523802
Goodearth Industries Ltd 526929
Goodearth Organic (India) Ltd [Wound-up] 524300
Govind Poy Oxygen Ltd 509586
GP Petroleums Ltd 532543 GULFPETRO
Grauer & Weil (India) Ltd 505710 GRAUWEIL
Gresoil (India) Ltd 530483
Gujarat Carbon & Industries Ltd 506457
Gujarat Fluorochemicals Ltd 542812 FLUOROCHEM
Gujarat Indo-Lube Ltd 523552
Gujarat Narmada Valley Fertilizers & Chemicals Ltd 500670 GNFC
Gujarat Oiland Industries Ltd (Wound Up) 507866
Gujarat Organics Ltd 501368
Gujarat Speciality Lubes Ltd 523880
Gulf Oil India Ltd - Merged 511026 GULFOIL
Gulf Oil Lubricants India Ltd 538567 GULFOILLUB
Gulshan Sugars & Chemicals Ltd(merged) 524184
Haryana Leather Chemicals Ltd 524080
Hemo Organic Ltd 524590
Hico Products Ltd 506461
Hi-Green Carbon Ltd 91663 HIGREEN
Hilltone Industrial Gases Ltd 40441
Himadri Speciality Chemical Ltd 500184 HSCL
Hindcon Chemicals Ltd 535053 HINDCON
Hindustan Industrial Chemicals Ltd 524679 HINDINDCHM
Hindustan Organic Chemicals Ltd 500449 HOCL
Hindustan Oxygen Gas Ltd 509660
HP Adhesives Ltd 543433 HPAL
Hubergroup India Pvt Ltd 523886 MICRO
I G Petrochemicals Ltd 500199 IGPL
IBP Co. Ltd(merged) 500198 IBP
Iccon Oil & Specialities Ltd 523766
India Carbon Ltd 40012
India Gelatine & Chemicals Ltd 531253
Indian Electro Chemicals Ltd 506490
Indo Amines Ltd 524648 INDOAMIN
Indo Borax & Chemicals Ltd 524342 INDOBORAX
Indo Gulf Industries Ltd 506945
Indo Vanillon Chemicals Ltd 531267
Indu Nissan Oxo Chemicals Industries Ltd 500208 INDUNISSAN
Inox Air Products Pvt Ltd 526534 INDOXYGEN
Insilco Ltd 500211 INSILCO
Iota Chemiculture Ltd(Liquidated) 524630
IVP Ltd 507580 IVP
J F Laboratories Ltd 523804 JFLABS
J.G.Chemicals Ltd 544138 JGCHEM
J.R. Organics Ltd 506650
Jay Agrochem Ltd (Wound Up) 513504
Jayant Agro Organics Ltd 524330 JAYAGROGN
Jocil Ltd 500561 JOCIL
Jubilant Industries Ltd 533320 JUBLINDS
Jubilant Ingrevia Ltd 543271 JUBLINGREA
Jyoti Resins and Adhesives Ltd 514448
K P Gelatines & Chemicals India Ltd (Wound-up) 524741
Kamar Chemicals & Industries Ltd 531001
Kanchi Karpooram Ltd 538896
Kanoria Chemicals & Industries Ltd 506525 KANORICHEM
Kanva Hydro Chem Ltd 524685
Karnataka Chemical Industries Corp Ltd 530105
Karnav Leather Chemicals Ltd 524432
Keltech Energies Ltd 506528
Kesar Petroproducts Ltd 524174
Kilburn Chemicals Ltd 524699
Kings India Chemicals Corporation Ltd 524214
Kothari Polymers Ltd 40360
Krishna Plastochem Ltd (Wound Up) 524254
Laxmi Organic Industries Ltd 543277 LXCHEM
Lime Chemicals Ltd 507759
Linde India Ltd 523457 LINDEINDIA
Link Pharma Chem Ltd 524748
Lords Chemicals Ltd 530039
M.P. Carbide & Chemicals Ltd 506925
Madras Petrochem Ltd 500261
Maha Chemicals Ltd (Wound-up) 524556
Maharashtra Explosives Ltd (Wound-up) 506871
Maharashtra Polybutenes Ltd 524232
Mangalam Organics Ltd 514418 MANORG
Mark Omega Organic Industries Ltd 524681
Maruti Industrial Carbohydrates Ltd 524814
Maruti Organics Ltd 524402 MARUTIORNG
Master Chemicals Ltd 506867
Mehta Rubber Chemcials Ltd 526536
Mehta Sulfites (India) Ltd 530029
mk Aromatics Ltd 531011
Motorol (I) Ltd 508965 MOTOROL
Motorol Enterprises Ltd 523049 RINKIPETRO
Motorol Speciality Oils Ltd 506954
MTZ Industries Ltd 500275 METAZINC
Murablack India Ltd 523578 MURABLACK
Nacro Chemicals Ltd 524350
Nariman Point Chemical Industries Ltd 524224
National Oxygen Ltd 507813 NOL
Navin Fluorine International Ltd 532504 NAVINFLUOR
Neogen Chemicals Ltd 542665 NEOGEN
Newton Engineering & Chemicals Ltd 524474
Nikhil Adhesives Ltd 526159
Niraj Petrochemicals Ltd 500454 NIRAJPETRO
Nitta Gelatin India Ltd 506532 KERALACHEM
NLC Nalco India Ltd 524101 NALCOCHEM
Noble Explochem Ltd 506991
NOCIL Ltd 500730 NOCIL
Nouryon Chemical India Pvt Ltd 500082 CENTAKCHEM
Nova Chemie (India) Ltd 40188
Ojas Technochem Products Ltd(wound-up) 526427
Omkar Speciality Chemicals Ltd 533317 OMKARCHEM
Organic Coatings Ltd 531157
Orient Organics Ltd 524766
Oriental Aromatics Ltd 500078 OAL
Oriental Carbon & Chemicals Ltd 506579 OCCL
Orissaa Organics Ltd 524392
Oswali Chemicals Ltd 506916
Padmanabh Industries Ltd 526905
Paintex Chemicals (Bombay) Ltd 524178
Paragon Fine and Speciality Chemical Ltd 91901 PARAGON
Paschim Petrochem Ltd 531005
Paushak Ltd 532742
PCBL Ltd 506590 PCBL
Pentasia Chemicals Ltd (Merged) 507739
Pidilite Industries Ltd 500331 PIDILITIND
Pinky Chemicals Ltd 524671
Plastiblends India Ltd 523648 PLASTIBLEN
Platinum Industries Ltd 544134 PLATIND
Polyolefins Industries Ltd (Merged) 506610
Premier Explosives Ltd 526247 PREMEXPLN
Privi Speciality Chemicals Ltd 530117 PRIVISCL
Protchem Industries (India) Ltd 524117
Rain Calcining Ltd(merged) 532153 RAINCALCIN
Rathi India Ltd 506959
Refnol Resins & Chemicals Ltd(Merged) 530815
Rencal Chemicals (India) Ltd 524510
Resonance Specialities Ltd 524218
Revati Organics Ltd 524504
Rhodia Specialty Chemicals India Ltd(Merged) 506230 ALBRMORARJ
Rite Zone Chemcon India Ltd 535489 RITEZONE
Ritesh International Ltd 519097
Rock Hard Petro Chemical Industries Ltd 524194
Rossari Biotech Ltd 543213 ROSSARI
Rukmani Metals & Gaseous Ltd 40695
S H Kelkar & Company Ltd 539450 SHK
S K R Chemicals Ltd 530371
Sadhana Nitro Chem Ltd 506642 SADHNANIQ
Salvigor Laboratories Ltd (Merged) 524268
Sanderson Industries Ltd 507728 SANDERIND
Sanginita Chemicals Ltd 538408 SANGINITA
Sarang Chemicals Ltd 532031
Searsole Chemicals Ltd (Wound-up) 506644
Seya Industries Ltd 524324 SEYAIND
Shaper Chemicals Ltd (Wound-up) 524566
Shayona Petrochem Ltd 531538
Shentracon Chemicals Ltd 530757
Shree Benzophen Industries Ltd 531389
Shree Neelachal Laboratories Ltd 531487
Shri Ambuja Petro Chemicals Ltd 506742
Shri Aster Silicates Ltd 533219 SHRIASTER
Shri Nicosect Ltd 526437
SI Group - India Ltd 506460 SIGROUPIND
SMZS Chemicals Ltd(wound-up) 524160 SMZSCHEM
Solar Industries India Ltd 532725 SOLARINDS
Sonal Sil Chem Ltd 524673
Southern Gas Ltd 509910
Speciality Petrolubes Ltd 523525
Sree Rayalaseema Hi-Strength Hypo Ltd 532842 SRHHYPOLTD
Sree Rayalaseema Petrochemicals Ltd (Merged) 524618
Sreechem Resins Ltd 514248
SRF Ltd 503806 SRF
SRHHL Industries Ltd (Merged) 524410 SRHHLINDST
Sterling Biotech Ltd 512299 STERLINBIO
Sudev Chemicals Ltd 40666
Sun Star Chemicals Ltd 524536 SUNSTRCHEM
Sunshield Chemicals Ltd 530845
Sunstar Lubricants Ltd 524452 SUNSTARLUB
Superior Air Products Ltd (Merged) 526469
Swarnajyothi Agrotech & Power Ltd 590090
Tamil Nadu Industrial Explosives Ltd 524028
Tamil Nadu Petro Products Ltd 500777 TNPETRO
Tanfac Industries Ltd 506854 TANFACIND
Tata Chemicals Ltd 500770 TATACHEM
Tatva Chintan Pharma Chem Ltd 543321 TATVA
TECIL Chemical & Hydro Power Ltd 506680 TECILCHEM
Tetrahedron Ltd 40308
Thirani Chemicals Ltd (Merged) 524125
Thirumalai Chemicals Ltd 500412 TIRUMALCHM
Tide Water Oil Co (I) Ltd 590005 TIDEWATER
Tirupati Inks Ltd 533258
Transpek Industry Ltd 506687 TRANSPEK
Tria Fine Chem Ltd 524721
Tribology India Ltd 40171
Trigon Zinco Ltd 530287
Tulasee Bio-Ethanol Ltd 524514
U P Lime Chem Ltd 524677
Unique Oils India Ltd 523250
Urvi Chemicals & Allied Industries Ltd 501371
Vadilal Chemicals Ltd 40485
Vadivarhe Speciality Chemicals Ltd 538429 VSCL
Valiant Organics Ltd 540145 VALIANTORG
VBC Industries Ltd 524310
Vibros Organics Ltd 530487
Vijayshree Chemicals (India) Ltd 524312
Vikas Wsp Ltd 519307 VIKASWSP
Vinati Organics Ltd 524200 VINATIORGA
Vishnu Chemicals Ltd 516072 VISHNU
Vision Organics Ltd 532383 VISIONLTD
Vital Chemtech Ltd 535490 VITAL
Yasho Industries Ltd 541167 YASHO
Yug Decor Ltd 540550

Share Holding

Category No. of shares Percentage
Total Foreign 44371 0.73
Total Institutions 350 0.01
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 69089 1.14
Total Promoters 4697489 77.65
Total Public & others 1238288 20.47
Total 6049587 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About Narmada Gelatines Ltd

Narmada Gelatines Ltd., formerly known as Shaw Wallace Gelatines was incorporated on 13 Jan.'61 as Leiner-Knit Gelatin Company Pvt. Ltd. In 1978, the Original Promoters, P Leiner & Sons fully divested in favour of Shah Wallace & Company. In 1979, the name of the Company was changed to Shaw Wallace Gelatines Limited, and in the year 2002, the Company was renamed as Narmada Gelatines Limited. The company manufactures Gelatine, Ossein, Di-Calcium Phosphate and Bone Meal. It has manufacturing facility located at Jabalpur (M.P.). Gelatine is basically a protein derivative of collagen, with a wide variety of end users. It is mostly used in the pharmaceutical, food and photographic industries. The company came out with an issue of PCDs in Dec.'94 to part-finance the expansion of existing capacity of production of gelatine from 1500 tpa to 2000 tpa. In 1994-95, the company made a breakthrough in exports of gelatine of pharmaceutical grade to developed countries, and edible grade to Japan and the Netherlands. Crushed bones of different sizes are washed, de-greased and processed for de-mineralisation. In de-mineralisation, the bones are treated with chilled dilute mineral acid in wooden vats to remove calcium phosphate from the bone pieces. This results in soft bones which are called ossein. After acid-free wash, this goes through alkaline treatment to remove unwanted proteins, fats and sugars, improving the purity of the collagen. The resultant product after refining is gelatine. Company consolidated its position in exporting pharmaceutical and edible grades of Gelatine to developed countries. Company has projected aprox. 134% Export, taking efforts to enter into the Japanese market to export of Ossein. Company has accredited with ISO-9002 Certificate by BVQI. In 2008, Company expanded the capacity of gelatine production from 2100 MTs to 2400 MTs per annum.

Narmada Gelatines Ltd Chairman Speech

Narmada Gelatines Ltd Company History

Narmada Gelatines Ltd., formerly known as Shaw Wallace Gelatines was incorporated on 13 Jan.'61 as Leiner-Knit Gelatin Company Pvt. Ltd. In 1978, the Original Promoters, P Leiner & Sons fully divested in favour of Shah Wallace & Company. In 1979, the name of the Company was changed to Shaw Wallace Gelatines Limited, and in the year 2002, the Company was renamed as Narmada Gelatines Limited. The company manufactures Gelatine, Ossein, Di-Calcium Phosphate and Bone Meal. It has manufacturing facility located at Jabalpur (M.P.). Gelatine is basically a protein derivative of collagen, with a wide variety of end users. It is mostly used in the pharmaceutical, food and photographic industries. The company came out with an issue of PCDs in Dec.'94 to part-finance the expansion of existing capacity of production of gelatine from 1500 tpa to 2000 tpa. In 1994-95, the company made a breakthrough in exports of gelatine of pharmaceutical grade to developed countries, and edible grade to Japan and the Netherlands. Crushed bones of different sizes are washed, de-greased and processed for de-mineralisation. In de-mineralisation, the bones are treated with chilled dilute mineral acid in wooden vats to remove calcium phosphate from the bone pieces. This results in soft bones which are called ossein. After acid-free wash, this goes through alkaline treatment to remove unwanted proteins, fats and sugars, improving the purity of the collagen. The resultant product after refining is gelatine. Company consolidated its position in exporting pharmaceutical and edible grades of Gelatine to developed countries. Company has projected aprox. 134% Export, taking efforts to enter into the Japanese market to export of Ossein. Company has accredited with ISO-9002 Certificate by BVQI. In 2008, Company expanded the capacity of gelatine production from 2100 MTs to 2400 MTs per annum.

Narmada Gelatines Ltd Directors Reports

To the Members,

The Board of Directors are pleased to present the 62nd Annual Report on the business and operations of the company Narmada Gelatines Limited (the Company) along with the audited financial statements for the financial year ended 31st March, 2023.

Financial Highlights ( lakh)

2022-23 2021-22

Revenue from operations

19,114.14 15,736.34

Other income

229.21 320.21

Total Income

19,343.35 16,056.56

Total expenses

17,361.66 14,513.94

Profit before tax

1,981.68 1,542.62

Tax Expense

453.40 308.71

Profit after taxation

1528.28 1,233.91

Other Comprehensive income:

Re-measurements of net

defined benefit plans

6.38 (12.89)

Net Profit for the year

1521.90 1,246.80

Operating Performance

During the financial year 2022-23, the revenue from operations grew 21.5% from Rs. 157.36 crores in the previous year, to Rs. 191.14 crores. Profit After Tax for the year grew by 23.8% to Rs. 15.28 crores vs. Rs. 12.33 crores in the previous year

The growth revenues and profits was led by increase in sales volumes as well as stronger prices of both, Gelatin and DCP.

Earnings before interest, taxes and depreciation and amortisation (EBITDA) stood at Rs. 22.04 crores, higher than the previous year by 25%. Consequently, the Earnings per share increased to 25.26 as compared to 20.40 in 2021-22.

Dividends

During the year under review, the Company paid to its shareholders a special interim dividend of Rs. 100 (Rupees One hundred only) per equity share, i.e. 1000% per share, of the face value of Rs. 10 (Rupee ten only). The dividend payout for the financial year 2022-23 amounted to Rs. 60.49 crore (Rupees Sixty crores forty nine lakh only) to those equity shareholders whose names appeared in the Register of Members as on 19th December, 2022 (Record Date) as against the total final dividend of Rs. 10 (Rupees ten only) per equity share, i.e. 100% per share, of the face value of Rs.10 (Rupee ten only) paid for the previous financial year 2021 -22 [Dividend payout for the FY 2021-22 amounts to Rs. 6.04 crores (Rupees Six crores four lakh only)]. The Board of Directors have decided to treat the above special interim dividend paid during the year as Final dividend and, hence do not recommended further dividend for the financial year under review.

Share Capital

The Paid-up Equity Share Capital of the Company as on 31st March 2023 was 604.96 lacs comprising 60,49,587 equity shares of Rs. 10/- each. During the year under review, your company has neither issued any shares with differential voting rights nor granted any stock options or sweat equity shares. The Company has paid listing fees for the financial year 2023-24 to the Bombay Stock Exchange Ltd., where its equity shares are listed.

Transfer to Reserves

As permitted under the Act, the Board does not propose to transfer any amount to General Reserve, but has decided to retain the entire

amount of profit for the financial year 2022-23 in the profit and loss account.

Transfer of shares by Alfamont (Mauritius) Limited (Holding Company)

A Share Purchase Agreement ("SPA") was executed on June 9, 2023, by and between Alfamont (Mauritius) Limited, Promoter of the Company, with Pioneer Jellice India Private Limited (CIN: U24295TN1991PTC060630) ("PJIPL") and Ashok Matches and Timber Industries Private Ltd. (CIN: U24291TN2000PTC045347) ("AMTIPL") for sale of the entire stake of 45,37,189 fully paid up equity shares of Rs. 10/- each, held by the Promoter, constituting 75% of the fully diluted voting share capital in the Company, at a price of Rs. 229/- (Rupees Two Hundred and Twenty Nine only) per equity share. PJIPL will acquire 24,95,454 equity shares of Rs. 10/- each, whereas AMTIPL will acquire 20,41,735 equity shares of Rs. 10/- each.

PJIPL is based out of Cuddalore, India and is part of Pioneer Asia Group in which Jellice Group holds 25% shares. Established in 1941, Jellice Group is one of the top 10 gelatin manufacturers in the world having headquarters in Sendai, Japan. Pioneer Jellice India and the Jellice Group have gelatin manufacturing facilities in Cuddalore (Tamil Nadu, India), Emmen (Netherlands) and Taiwan.

AMTIPL is carrying on, inter alia, the business of acquiring, purchasing, taking on lease or hire or by any other means any real estate and/or developing the same and erecting, constructing, maintaining and operating buildings and other superstructures of any kind.

Pursuant to the said acquisition by way of execution of SPA and on completion of transfer formalities, the Company will no longer be a subsidiary of Alfamont (Mauritius) Limited. The shareholders can view the SPA from the websites of the Company and BSE Limited for further information on this

Quality initiatives

The Company is committed to the highest levels of quality for its products and customer services. During the financial year 2022-23, the Company retained its ISO certification for Quality Management (ISO 9001:2015), EDQM Certification from European Directorate for the Quality of Medicines and Healthcare, DNV Management System Certification for Food Safety Management System Standard (ISO 22000:2005), KOSHER Certification and Halal Assurance System Certification.

Deposits from public

During the year under review, the Company has not accepted any deposits from public as defined under Chapter V of the Companies Act, 2013. No amount on account of principal or interest on deposits from public was outstanding as on the date of the balance sheet.

Particulars of Loans, Guarantees and Investments

Details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013 are given in the notes to the Financial Statements.

Corporate Social Responsibility (CSR)

In compliance with Section 135 of the Act, the Company has undertaken CSR activities and programs, excluding activities undertaken in pursuance of its normal course of business. Under Section 135 of the Act, the Company was required to spend Rs. 22.90 lakh (2%) of the average qualifying net profits of the last three financial years on CSR activities in financial year 2022-23. During the year under review, the Company has spent Rs.15.98 lakh and balance Rs. 6.92 lakh has been setoff from the previous year's excess spent on CSR activities as

approved by the Board of Directors. Accordingly, the Company has met its obligation of spending Rs. 22.90 lacs for financial year 2022-23.

The Annual Report on CSR containing the composition of the CSR Committee, salient features of the CSR Policy, details of activities, and other information as required under Companies (Corporate Social Responsibility Policy) Rules, 2014 are provided in Annexure -I attached to this Report. Since the average CSR obligation for the preceding three financial years i.e. financial year, 2019-20, 2020-21 and 2021-22 was less than Rs. 10 crores, the impact assessment report was not applicable for the year 2022-23. The CSR Policy may be accessed on the Company's website at the link: https://www.narmadagelatines.com.

Risk Management

The Risk Management Committee has been entrusted with the responsibility to assist the Board in (a) approving the Company's Risk Management Framework and (b) overseeing strategic, operational, financial, liquidity, security, regulatory, legal, environmental, human recourse, and other risks that have been identified and assessed to ensure that there is a sound Risk Management Policy in place to address such concerns/risks.

The Audit Committee has exercised additional oversight in the area of financial risks and controls. Major risks identified by the business and functions are systematically addressed through mitigating actions. The details of the Risk Management Committee, its terms of reference, key business risks identified and mitigation plans are set out in the Corporate Governance Report.

Vigil Mechanism / Whistle Blower Policy

The Company has a Vigil mechanism / Whistle-blower Policy in place to encourage and facilitate employees to report concerns about unethical behavior, actual/ suspected frauds and violation of Company's Code of Conduct or Ethics. The policy provides for adequate safeguards against victimisation of persons who avail the same and provides for direct access to the chairperson of the Audit Committee. The Audit Committee of the Company oversees the implementation of the Whistle- Blower Policy. The Committee affirms that no complaint has been received under the Whistle-Blower Policy/ Vigil Mechanism and no personnel had been denied access to the Chairman of the Audit Committee.

Information on Whistle-Blower Policy is available on the website of the Company at https://www.narmadagelatines.com and in the Corporate Governance Report.

Reporting of Frauds

There were no instances of fraud or suspected frauds reported during the year under review, which required the Statutory Auditors to report to the Audit Committee and / or Board under Section 143(12) of the Act and the rules made thereunder.

Subsidiaries, Joint Ventures and Associate Companies

The Company does not have any subsidiary, joint ventures or associate companies.

Nomination and Remuneration Policy

The policy of the Company is to have an appropriate number of executive and independent directors on the board. The policy of the Company on directors' appointment and remuneration, etc. as required under Section 178 of the Companies Act, 2013, is available on the website (www.narmadagelatines.com) and in the Corporate Governance Report. The remuneration paid to directors is as per the terms laid down in the Nomination & Remuneration Policy of the

Company.

The Company has a Nomination and Remuneration Committee which makes recommendation to the Board with regard to the appointment of new Directors and Key Managerial Personnel. This policy on nomination and remuneration of Directors, Key Managerial Personnel and Senior Management has been formulated in terms of the provisions of the Companies Act, 2013 and the Listing Regulations as amended from ti me to time.

The main objectives of the policy are:

• To lay down criteria and terms and conditions with regard to identifying persons who are qualified to become Directors (Executive and Non-Executive) and persons who may be appointed in senior management and key managerial positions.

• To determine remuneration based on the Company's size and financial position and trends and practices on remuneration prevailing in peer companies and in the industry.

• To carry out evaluation of the performance of Directors, as well as key managerial and senior management personnel.

• To provide them rewards linked directly to their effort, performance, dedication and achievement relating to the Company's operations.

• To retain, motivate and promote talent and to ensure long term sustainability of talented managerial persons and to create competitive advantage.

Directors and Key Managerial Personnel

Re-appointment of Wholetime Director

The Board of Directors at their meeting held on 16th May, 2023, subject to approval of the shareholders, approved the re-appointment of Mr. Ashok K Kapur (DIN: 00126807) as the Whole-time Director of the Company for a further period of one year commencing from 1 st June, 2023 to 31st May, 2024.

Special resolution for the re-appointment of Mr. Ashok K Kapur as the Whole-time Director of the Company is being placed for the approval of the shareholders of the Company at the ensuing AGM. The Board of Directors, and Nomination and Remuneration Committee of the Company recommends his re-appointment as the Whole-time Director of the Company.

In terms of requirement of Listing Regulations, the Board has identified core skills, expertise and competencies of the Directors in the context of the Company's businesses for effective functioning, which are detailed in the Corporate Governance Report.

Attention of Shareholders is invited to the relevant items of the Notice of the Annual General Meeting and the Notes thereto. Brief resume of the Directors proposed to be appointed/ reappointed, nature of their expertise in specific functional areas and names of companies in which they hold directorship and membership/ chairmanship of committees of the Board, as stipulated under Regulation 36 of the Listing Regulations are given in the section on Corporate Governance in this Annual Report.

Pecuniary relationship or transactions with the Company

During the year under review, except Mr. Ravindra K Raje, no other non-executive directors of the Company had pecuniary relationship or transactions with the Company, other than sitting fees and reimbursement of expenses incurred by them for the purpose of

attending meetings of the Board/Committee of the Company. Declaration from directors

The Company has received necessary declarations under Section 149(7) of the Companies Act, 2013 and Regulation 25(8) of the SEBI Listing Regulations, from the Independent Directors stating that they meet the prescribed criteria for independence. All Independent Directors have affirmed compliance to the code of conduct for Independent Directors as prescribed in Schedule IV to the Companies Act, 2013.

The Company has also received from them declaration to compliance of Rule 6(1) & (2) of the Companies (Appointment and Qualifications of Directors) Rules, 2014, regarding online registration with the 'Indian Institute of Corporate Affairs', for inclusion/ renewal of their names in the data bank of Independent Directors.

With regard to integrity, expertise and experience (including the proficiency) of the Independent Directors appointed / reappointed during the Financial year 2022-23, the Board of Directors have taken on record the declarations and confirmations submitted by the independent directors and is of the opinion that all the Independent Directors are persons of integrity and possess relevant expertise and experience and their association as Directors will be of immense benefit to the Company.

With regard to proficiency of the Independent Directors, ascertained from the online proficiency self-assessment test conducted by the institute, as notified under Sub-Section (1) of Section 150 of the Act, the Board of Directors has taken on record the declarations submitted by Independent Directors that they are exempt from appearing i n the test.

None of the Directors of the Company are related inter-se, in terms of Section 2(77) of the Act including Rules there under.

None of the Directors of the Company are disqualified for being appointed as directors as specified under Section 164(2) of the Act and Rules there under.

Key Managerial Personnel

Pursuant to the provisions of Section 203 of the Companies Act, 2013, Mr. Ashok K Kapur, Whole-time Director, Mr. Mahesh Verma Chief Financial Officer and Ms. Meenu Sharma, Company Secretary are the Key Managerial Personnel of the Company as on 31st March, 2023.

Board Evaluation

The Nomination & Remuneration Committee and the Board have laid down the manner in which a formal annual evaluation of the performance of the Board, Committees, Chairman and individual directors has to be made. The Board of Directors has carried out an annual evaluation of its own performance, Board committees, and individual directors pursuant to the provisions of the Act, SEBI Listing Regulations and the Guidance Note on Board Evaluation issued by the Securities and Exchange Board of India.

The Board evaluated its own performance, Board Committees as well as the individual directors performance after seeking inputs from all the directors/members and also on the basis of criteria such as the Board composition and structure, effectiveness of board processes, information and functioning, etc.

The independent directors at their separate meeting reviewed the performance of non-independent directors, the Board as a whole and Chairman of the Company, taking into account the views of executive directors and non-executive directors.

The Board and the Nomination and Remuneration Committee reviewed the performance of individual directors on the basis of criteria such as the contribution of the individual director to the Board and Committee meetings like preparedness on the issues to be discussed, meaningful and constructive contribution and inputs in meetings, etc.

Performance evaluation of independent directors was done by the entire Board, excluding the independent director being evaluated. The manner in which the evaluation was carried out is covered in the Corporate Governance Report.

Board and Committee Meetings

The Board meets at regular intervals to discuss and decide on company's business policies and strategies. In case of special and urgent business, the Board/Committee's approval is taken by passing resolutions through circulation, or by calling Board/Committee meetings at a shorter notice, as permitted by law.

The Company has complied with Secretarial Standards issued by the Institute of Company Secretaries of India on Board meetings and Annual General Meetings. The agenda for the Board and Committee meetings includes detailed notes on the items to be discussed to enable the Directors to take an informed decision.

During the financial year under review, five Board Meetings and four Audit Committee Meetings were convened and held, the details of which are given in the Corporate Governance Report. The intervening gap between two Meetings was within the period prescribed under the Companies Act, 2013.

A detailed note on the composition of the Board and its committees is provided in the Corporate Governance Report.

Meeting of Independent Directors

As per provisions of Schedule IV to the Companies Act, 2013, the Independent Directors are required to hold at least one meeting in a financial year, without the attendance of Non-independent Directors and members of management. During the financial year 2022-23, the Independent Directors have held one separate meeting on February 10th, 2023.

Directors' Responsibility Statement

Pursuant to the requirement of Section 134(5) of the Act, the Board of Directors, to the best of its knowledge and ability, confirm that:

a. in the preparation of the annual financial statements for the year ended March 31, 2023, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;

b. appropriate accounting policies have been selected and applied consistently and judgements and estimates made are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at March 31, 2023 and of the profit of the Company for the year ended on that date;

c. proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

d. the annual financial statements have been prepared on a going concern basis;

e. proper internal financial controls have been followed and that such financial controls are adequate and are operating effectively; and

f. proper systems to ensure compliance with the provisions of all

applicable laws are in place and were adequate and operating effectively.

Related Party Transactions

The transactions with related parties entered into during the financial year were on arm's length basis and were in the ordinary course of business. There are no materially significant related party transactions made by the Company with Promoters, Directors, Key Managerial Personnel or other designated persons which may have a potential conflict with the interest of the Company at large.

Particulars of contracts or arrangements with related parties referred to in Section 188(1) of the Companies Act, 2013 in Form AOC-2 are set out in the Notes to Financial Statements forming part of the Annual Report. None of the Directors has any pecuniary relationships or transactions with the Company or vice versa, except Mr. Ravindra K Raje who is in receipt of fees in his professional capacity for being appointed as a Consultant/Advisor to the Company owing to his qualification and expertise on various matters concerning affairs of the Company duly approved by the Audit Committee, the Nomination and Remuneration Committee and the Board of Directors of the Company with effect from 1st March, 2022.

Statutory Auditors

Pursuant to the provisions of Section 139 of the Act read with Companies (Audit and Auditors) Rules, 2014, as amended from time to time, M/s Lodha and Company, Mumbai, Chartered Accountants (Firm Registration No.301051 E), were appointed as the statutory auditors of the company at the 61st Annual General Meeting of the company held on 22nd September, 2022, to hold office for the second term of five years from the conclusion of 61st Annual General Meeting of the Company, till the conclusion of 66th Annual General Meeting to be held in the year 2027.

The requirement for the annual ratification of auditors' appointment at the AGM has been omitted pursuant to Companies (Amendment) Act, 2017, notified on May 7, 2018.

Report of Statutory Aud itors

The Statutory Auditors, M/s Lodha and Company, Mumbai, Chartered Accountants, have submitted their Report on the Financial Statements of the Company for the financial year 2022- 23, which forms part of this Annual Report. The Notes on Financial Statements referred to in the Auditors' Report for the year 2022- 23 are self-explanatory. There are no observations, qualifications, reservations or adverse remarks in the Auditor's Report that call for any explanation.

Cost records and cost audit

Maintenance of cost records and requirement of cost audit as prescribed under the provisions of Section 148(1) of the Companies Act, 2013 are not applicable for the products manufactured by the Company.

Secretarial Auditor and their report

Dr. Asim Kumar Chattopadhyay, Company Secretary, was appointed as Secretarial Auditor of your Company for the financial year 2022-23 pursuant to Section 204 of the Companies Act, 2013 and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.

The Secretarial Audit Report is annexed to this Report as Annexure - II.

There are no qualifications, observations or adverse remarks of the Secretarial Auditors in the Report issued by them for the financial year 2022-23 which call for any explanation from the Board of Directors.

Transfer of Unpaid and Unclaimed amounts to IEPF

Pursuant to the applicable provisions of the Act, read with the IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 ('the Rules') as amended, all unpaid or unclaimed dividends which were required to be transferred by the Company to the IEPF were transferred to IEPF Authority.

The Company has also transferred shares in respect of which dividend amount remained unpaid/ unclaimed for a consecutive period of seven years or more to IEPF Authority within stipulated time.

Pursuant to the provisions of Section 124 of the Companies Act, 2013, during the financial year, the declared dividends which remained unpaid or unclaimed for a period of 7 years have been transferred by the Company to the Investor Education and Protection Fund (IEPF) established by the Central Government, as detailed in the Corporate Governance Report.

The details of unpaid / unclaimed dividend and the shares transferred to IEPF Authority are available on the website of the company at https://www.narmadagelatines.com.

Significant and Material Order passed by the Regulators

There are no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and the Company's operations in future.

Corporate Governance Report

The Report on Corporate Governance as stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 forms part of the Annual Report. The Whole- time Director's declaration regarding compliance with the Company's Code of Business Conduct and Ethics for Directors and Management Personnel forms part of the Corporate Governance Report. As required by the Listing Regulations the certificate on Corporate Governance for the year ended 31st March, 2023 issued by Dr. Asim Kumar Chattopadhyay, Company Secretary in Practice, is annexed to this Report.

Management Discussion and Analysis

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, detailed review of operation, performance and future outlook of the Company is presented under Management Discussion and Analysis Report in a separate section and forms part of the Annual Report.

Energy Conservation, Technology Absorption and Foreign Exchange Earnings and Outgo

The particulars relating to energy conservation, technology absorption, foreign exchange earnings and outgo, as required to be disclosed under Section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of The Companies (Accounts) Rules, 2014 is annexed to this Report as Annexure - III.

Annual Return

As provided under Section 92(3) & 134(3)(a) of the Act, the Annual Return for FY 2021-22 is available on the website of the Company at https://www.narmadagelatines.com.

Particulars of Employees

None of the employees of the Company is in receipt of remuneration exceeding the limits prescribed under Section 197(12) of the Companies Act, 2013 read with Rules 5(2) and 5(3) of The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.

Disclosures pertaining to remuneration and other details in respect of directors and employees of the Company as required under Section 197(12) of the Companies Act, 2013 read with Rule 5(1) of The

Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is annexed to this Report as Annexure - IV.

Disclosure under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013

All the employees in the Company are considered equal. There is no discrimination between individuals at any point on the basis of race, colour, gender, religion, origin, sexual orientation or age. Every individual is expected to treat his/her colleagues with respect and dignity.

The Company has in place a policy for prevention of sexual harassment at workplace. This policy of the Company is in line with the requirements of the Sexual Harassment of Women at the Workplace (Prevention, Prohibition & Redressal) Act, 2013. All employees (permanent, contractual, temporary and trainees) are covered under this policy. An Internal Complaints Committee is in place to redress the complaints received regarding sexual harassment. No complaint was received by the Company during the financial year ended 31st March, 2023.

Material changes and commitments affecting the financial position of the Company

There have been no material changes and commitments affecting the financial position of the Company which have occurred between the end of the financial year of the Company to which the financial statements relate and the date of this report.

Appreciation

The Directors wish to convey their deep appreciation to all the employees, customers, vendors, investors, and consultants/ advisors of the Company for their sincere and dedicated services as well as their collective contribution to the Company's performance.

The Directors also thank the Central and the State Governments, statutory authorities, bankers, and business associates and all the stakeholders for their continued interest and valued support

For and on behalf of the Board

Prakash M Nene

Ashok K. Kapur

Chairman

Whole-time Director

Place: Jabalpur

Date: 7th July, 2023

   

Narmada Gelatines Ltd Company Background

Prakash M Nene
Incorporation Year1961
Registered OfficeCARAVS Room No.28,15 Civil Lines
Jabalpur,Madhya Pradesh-482001
Telephone91-0761-2678627,Managing Director
Fax91-0761-2678864
Company Secretary
AuditorLodha & Co
Face Value10
Market Lot1
ListingBSE,
RegistrarCB Management Services Ltd
P-22,Bondel Road, ,Kolkata-700019

Narmada Gelatines Ltd Company Management

Director NameDirector DesignationYear
Prakash M NeneChairman & Independent Directo2023
KAILASAM KRISHNAMOORTHYIndependent Non Exe. Director2023
Ravindra K RajeNon-Exec & Non-Independent Dir2023
Drushti DesaiNon-Exec & Non-Independent Dir2023
GAURANG ARUNKUMAR SHAHNon-Exec & Non-Independent Dir2023
Ashok Kumar KapoorE D & Wholetime Director2023

Narmada Gelatines Ltd Listing Information

Narmada Gelatines Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
GelatinMT00091.7532
Dicalcium PhosphateMT00029.7713
OsseinMT0003.7296
Bone Product-OthersMT0000.4935
Bone MealMT0000
Excise DutyNA0000
OthersNA0000
Trade DiscountNA0000

Contact us Contact us